SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ejersted C, Andreassen TT, Oxlund H, Jørgensen PH, Bak B, Häggblad J, Tørring O, Nilsson MHL 1993 Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res 8:10971101.
  • 2
    Ejersted C, Andreassen TT, Nilsson MHL, Oxlund H 1994 Human parathyroid hormone (1-34) increases bone formation and strength of cortical bone in aged rats. Eur J Endocrinol 130:201207.
  • 3
    Wronski TJ, Yen C-F 1994 Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15:5158.
  • 4
    Baumann BD, Wronski TJ 1995 Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone 16:247253.
  • 5
    Mosekilde L, Danielsen CC, Søgaard CH, McOsker JE, Wronski TJ 1995 The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength-assessed in a sexually mature, ovariectomized rat model. Bone 16:223230.
  • 6
    Cheng P-T, Chan C, Müller K 1995 Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate. J Bone Miner Res 10:119126.
  • 7
    Sato Masahiko, Zeng GQ, Turner CH 1997 Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats. Endocrinology 138:43304337.
  • 8
    Ejersted C, Oxlund H, Andreassen TT 1998 Bisphosphonate maintains parathyroid hormone (1-34) induced cortical bone mass and mechanical competence in old rats. Calcif Tissue Int 62:316322.
  • 9
    Jørgensen PH, Bak B, Andreassen TT 1991 Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone. Bone 12:353359.
  • 10
    Andreassen TT, Jørgensen PH, Flyvbjerg A, Ørskov H, Oxlund H 1995 Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 10:10571067.
  • 11
    Oxlund H, Andersen NB, Ørtoft G, Ørskov H, Andreassen TT 1998 Growth hormone and mild exercise in combination markedly enhance cortical bone formation and strength in old rats. Endocrinology 139:18991904.
  • 12
    Mosekilde Li, Thomsen JS, Orhii PB, Kalu DN 1998 Growth hormone increases vertebral and femoral bone strength in osteopenic, ovariectomized, aged rats in a dose-dependent and site-specific manner. Bone 23:343352.
  • 13
    Prakasam G, Yeh JK, Chen M-M, Castro-Magana M, Liang CT, Aloia JF 1999 Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats. Bone 24:491497.
  • 14
    Ørtoft G, Andreassen TT, Oxlund H 1999 Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia. J Bone Miner Res 14:710721.
  • 15
    Mosekilde Li, Thomsen JS, Orhii PB, McCarter RJ, Mejia W, Kalu DN 1999 Additive effect of voluntary exercise and growth hormone treatment on bone strength assessed at four different skeletal sites in an aged rat model. Bone 24:7180.
  • 16
    Oxlund H, Ejersted C, Andreassen TT, Tørring O, Nilsson MHL 1993 Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. Calcif Tissue Int 53:394399.
  • 17
    Danielsen CC, Mosekilde L, Svenstrup B 1993 Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution. Calcif Tissue Int 52:2633.
  • 18
    Danielsen CC, Flyvbjerg A 1996 Insulin-like growth factor I as a predictor of cortical bone mass in a long-term study of ovariectomized and estrogen-treated rats. Bone 19:493498.
  • 19
    Aerssens J, Van Audekercke R, Geusens P, Schot LPC, Osman AA-H, Dequeker J 1993 Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: Influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment. Calcif Tissue Int 53:269277.
  • 20
    Ohnishi H, Nakamura T, Narusawa K, Murakami H, Abe M, Barbier A, Suzuki K 1997 Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats. Bone 21:335343.
  • 21
    Spencer EM, Si EC, Liu CC, Howard GA 1989 Parathyroid hormone potentiates the effect of insulin-like growth factor-I on bone formation. Acta Endocrinol 121:435442.
  • 22
    Stracke H, Schultz A, Moeller D, Rossol S, Schatz H 1984 Effect of growth hormone on osteoblasts and demonstration of somatomedin/IGF-I in bone organ culture. Acta Endocrinol 107:1624.
  • 23
    Maor G, Hochberg Z, Silbermann M 1989 Growth hormone stimulates the growth of mouse neonatal condylar cartilage in vitro. Acta Endocrinol 120:526532.
  • 24
    Maor G, Hochberg Z, von der Mark K, Heinegard D, Silbermann M 1989 Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells. Endocrinology 125:12391245.
  • 25
    Gunness M, Hock JM 1995 Anabolic effect of parathyroid hormone is not modified by supplementation with insulinlike growth factor I (IGF-I) or growth hormone in aged female rats fed an energy-restricted or ad libitum diet. Bone 16:199207.
  • 26
    Hock JM, Wood RJ 1995 Growth hormone does not enhance the anabolic effect of human parathyroid hormone (1-34) on bone in aging multiparous and virgin rats. Mech Ageing Dev 85:183197.
  • 27
    Bak B, Jørgensen PH, Andreassen TT 1990 Dose response of growth hormone on fracture healing in the rat. Acta Orthop Scand 61:5457.
  • 28
    Andreassen TT, Melsen F, Oxlund H 1996 The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged rats. J Bone Miner Res 11:10941102.
  • 29
    Mosekilde L, Tornvig L, Thomsen JS, Orhii PB, Banu J, Kalu DN 1999 PTH and GH have synergetic effect when used in intervention treatment in ovariectomized rats with established osteopenia. J Bone Miner Res (Suppl 1)14:S399.
  • 30
    Hayes WC 1991 Biomechanics of cortical and trabecular bone: Implications for assessment of fracture risk. In: MowVC, HayesWC (eds.) Basic Orthopaedic Biomechanics. Raven Press, New York, NY, U.S.A., pp. 93142.
  • 31
    Einhorn TA 1996 Biomechanics of bone. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, U.S.A., pp. 2537.
  • 32
    Martin B 1993 Aging and strength of bone as a structural material. Calcif Tissue Int 53(Suppl 1):S34S39.
  • 33
    Ruff CB, Hayes WC 1982 Subperiosteal expansion and cortical remodeling of the human femur and tibia with aging. Science 217:945948.
  • 34
    Bouxsein ML, Myers ER, Hayes WC 1996 Biomechanics of age-related fractures. In: MarcusR, FeldmanD, KelseyJ (eds.) Osteoporosis. Academic Press, San Diego, CA, U.S.A., pp. 373393.
  • 35
    Wüster C, Slenczka E, Ziegler R 1991 Increased prevalence of osteoporosis and arteriosclerosis in patients with conventionally substituted pituitary insufficiency: Is there a need for additional growth hormone substitution? Klin Wochenschr 69:769773.
  • 36
    Johansson AG, Burman P, Westermark K, Ljunghall S 1992 The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 232:447452.
  • 37
    Kaufman J-M, Taelman P, Vermeulen A, Vandeweghe M 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 74:118123.
  • 38
    Rosén T, Hansson T, Granhed H, Szucs J, Bengtsson B-Å 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol 129:201206.
  • 39
    Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 78:669674.
  • 40
    Rosén T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson B-Å 1997 Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240245.
  • 41
    Thorén M, Soop M, Degerblad M, Sääf M 1993 Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency. Acta Endocrinol 128(Suppl 2):4143.
  • 42
    Vandeweghe M, Taelman P, Kaufman J-M 1993 Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 39:409415.
  • 43
    Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM 1995 Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clin Endocrinol 42:627633.
  • 44
    Valk NK, Erdtsieck RJ, Algra D, Lamberts SWJ, Pols HAP 1995 Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: The effects on renal phosphate handling, bone turnover and bone mineral mass. Clin Endocrinol 43:317324.
  • 45
    Hansen TB, Brixen K, Vahl N, Jørgensen JOL, Christiansen JS, Mosekilde L, Hagen C 1996 Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: A double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab 81:33523359.
  • 46
    O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76:13441348.
  • 47
    Baum HBA, Biller BMK, Finkelstein JS, Cannistraro KB, Oppenheim DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A 1996 Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 125:883890.
  • 48
    Finkenstedt G, Gasser RW, Höfle G, Watfah C, Fridrich L 1997 Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: Results of a double-blind placebo-controlled study with open follow-up. Eur J Endocrinol 136:282289.
  • 49
    Johannsson G, Rosén T, Bosaeus I, Sjöstrom L, Bengtsson B-Å 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81:28652873.
  • 50
    Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J 1998 Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol 48:561568.
  • 51
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S 1998 Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and −5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy. J Bone Miner Res 13:891899.
  • 52
    Kotzmann H, Riedl M, Bernecker P, Clodi M, Kainberger F, Kaider A, Woloszczuk W, Luger A 1998 Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency. Calcif Tissue Int 62:4046.
  • 53
    Välimäki MJ, Salmela PI, Salmi J, Viikari J, Kataja M, Turunen H, Soppi E 1999 Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults. Eur J Endocrinol 140:545554.
  • 54
    Johansson AG, Engström BE, Ljunghall S, Karlsson FA, Burman P 1999 Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J Clin Endocrinol Metab 84:20022007.
  • 55
    Gomez JM, Gomez N, Fiter J, Soler J 2000 Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement. Horm Metab Res 32:6670.
  • 56
    Bravenboer N, Holzmann P, de Boer H, Roos JC, van der Veen EA, Lips P 1997 The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men. J Clin Endocrinol Metab 82:18181822.
  • 57
    Brixen K, Hansen TB, Hauge E, Vahl N, Jørgensen JOL, Christiansen JS, Mosekilde L, Hagen C, Melsen F 2000 Growth hormone treatment in adults with adult-onset growth hormone deficiency increases iliac crest trabecular bone turnover: A 1-year, double-blind, randomized, placebo-controlled study. J Bone Miner Res 15:293300.
  • 58
    Johannsson G, Bjarnason R, Bramnert M, Carlsson LMS, Degerblad M, Manhem P, Rosén T, Thorén M, Bengtsson B-Å 1996 The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J Clin Endocrinol Metab 81:15751581.
  • 59
    Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA 1997 Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82:550555.
  • 60
    Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF 1994 Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. J Bone Miner Res 9:13651370.
  • 61
    Brixen K, Kassem M, Nielsen HK, Loft AG, Flyvbjerg A, Mosekilde L 1995 Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: A dose response study. J Bone Miner Res 10:18651874.
  • 62
    Johansson AG, Lindh E, Blum WF, Kollerup G, Sørensen OH, Ljunghall S 1996 Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 81:4448.
  • 63
    Kruse H-P, Kuhlencordt F 1975 On an attempt to treat primary and secondary osteoporosis with human growth hormone. Horm Metab Res 7:488491.
  • 64
    Aloia JF, Zanzi I, Ellis K, Jowsey J, Roginsky M, Wallach S, Cohn SH 1976 Effects of growth hormone in osteoporosis. J Clin Endocrinol Metab 43:992999.
  • 65
    Aloia JF, Zanzi I, Vaswani A, Ellis K, Cohn SH 1977 Combination therapy for osteoporosis. Metabolism 26:787792.
  • 66
    Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH 1985 Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 34:124129.
  • 67
    Aloia JF, Vaswani A, Meunier PJ, Edouard CM, Arlot ME, Yeh JK, Cohn SH 1987 Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin. Calcif Tissue Int 40:253259.
  • 68
    Erdtsieck RJ, Pols HAP, Valk NK, van Ouwerkerk BM, Lamberts SWJ, Mulder P, Birkenhager JC 1995 Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: A placebo controlled trial. Clin Endocrinol 43:557565.
  • 69
    Gonnelli S, Cepollaro C, Montomoli M, Gennari L, Montagnani A, Palmieri R, Gennari C 1997 Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: A placebo controlled study. Clin Endocrinol 46:5561.
  • 70
    Sääf M, Hilding A, Thorén M, Troell S, Hall K 1999 Growth hormone treatment of osteoporotic postmenopausal women—a one-year placebo-controlled study. Eur J Endocrinol 140:390399.